Skip to main content

PharmEasy: The only online medical store which revises prices upwards after confirming the order

By Rajiv Shah 
For senior citizens — especially those without a family support system — ordering medicines online can be a great relief. Shruti and I have been doing this for the last couple of years, and with considerable success. We upload a prescription, receive a verification call from a doctor, and within two or three days, the medicines are delivered to our doorstep.
Given the stiff competition among online pharmacies, many of them offer rebates. Some even suggest switching to generic alternatives after we place the order. We sometimes agree, but we always make it clear that we won’t change brands for important medicines without consulting our doctor.
However, with competition has come unethical price manipulation.
In our experience, PharmEasy stands out as the worst offender. They initially attract you with a 27% discount. But after finalizing the cart, it drops to 24%. Even then, we’ve placed orders (we prefer cash on delivery). But after getting a confirmation, and just before dispatching the shipment, they increase the price of the medicines.
This happened to us in late April. We had ordered medicines worth over ₹5,000. While enjoying dosa at our favourite Chennai Express restaurant in Ahmedabad, I received an SMS informing me that the prices had been revised upward. Shocked, I canceled the order and left this review on the PharmEasy app:
> “After I ordered medicines at a certain price, PharmEasy hours later updated and revised the prices upward. Unethical — decided to cancel the order.”
They responded, asking us to email the order number. To our surprise, not only was the order canceled, but PharmEasy also removed the entire order history from our account! Still, on May 1, we emailed them with our phone number to find out if it had been an error.
Since then, we’ve received two responses. One, from Sandhya Nackwal on May 2, explained the revised pricing:
> “The products listed in the app are not linked to a fixed price. Thus, we share the estimated cost at the time of order placement, which can be either higher or lower than the actual price. We send you an SMS or push notification for the total discounted amount once your medicines are procured...”
The reply urged us to be patient and reorder. It added:
> “Sometimes, the MRP of medicines may vary depending on the stock received by the chemist. This variation is always due to manufacturer price changes. However, if the price on the packaging differs from the bill, please share an image highlighting the batch number so we can resolve the issue.”
Later, we received a phone call assuring us that this wouldn’t happen again and urging us to reorder. So we did, on May 3. I also sent another email on May 6:
> “Yours is the only platform that updates the price upwards after the order is placed and billed. Very strange, to say the least. We had to cancel the order twice, and now your representative tells us it won’t happen again, so he revived the cancelled order at the original price. Let’s see what happens now!”
But again, the prices were revised upward. After canceling the second order, we got another phone call with the same assurance. So we placed a third order — tempted by the best rebate.
This time, the total payable amount had gone down. Suspicious, I checked and realized they had simply reduced the quantity of medicines we had ordered while raising the prices of the rest. We canceled again and left this updated review:
> “Am forced to edit my review. Twice, after I ordered medicines, PharmEasy revised prices upward before delivery. Third time, they reduced the total amount but also reduced the number of medicines, while increasing some prices. Unethical, untrustworthy. Have canceled for the third time...”
It’s now been two weeks, and we keep getting calls from PharmEasy representatives. We hang up the moment we realize it’s them.
Out of curiosity, I browsed the app’s review section. To my dismay — but not surprise — many others have faced the same issue.
Prashant Arya (April 23):
> “I recently purchased a pharmaceutical product from this platform, and unfortunately, my experience was disappointing. The listed price was ₹80, but the final bill showed ₹100. Plus, additional platform fees made the overall cost even higher. The advertised price does not reflect the actual cost at checkout. Misleading and frustrating.”
M Mohan (January 18):
> “Prices changed between adding items to the cart and checkout. Discounts were shown initially but vanished later. Customer support was poor and unhelpful.”
Namrata Behera (April 30):
> “Most products are listed at a fair price, but at checkout, the price increases…”
Vedant Mule (May 12):
> “Don’t use this app. There’s a huge difference in the price shown on the product page and the cart…"
Each of these users gave a one-star rating. I don’t know whether PharmEasy is losing customers. Maybe not — they claim to have over four crore “satisfied” customers. Perhaps that’s why they don’t care about negative reviews.
But I still wonder: has PharmEasy ever tried to find out why no other app makes such bizarre upward price revisions after confirming an order?

Comments

TRENDING

Countrywide protest by gig workers puts spotlight on algorithmic exploitation

By A Representative   A nationwide protest led largely by women gig and platform workers was held across several states on February 3, with the Gig & Platform Service Workers Union (GIPSWU) claiming the mobilisation as a success and a strong assertion of workers’ rights against what it described as widespread exploitation by digital platform companies. Demonstrations took place in Delhi, Rajasthan, Karnataka, Maharashtra and other states, covering major cities including New Delhi, Jaipur, Bengaluru and Mumbai, along with multiple districts across the country.

Swami Vivekananda's views on caste and sexuality were 'painfully' regressive

By Bhaskar Sur* Swami Vivekananda now belongs more to the modern Hindu mythology than reality. It makes a daunting job to discover the real human being who knew unemployment, humiliation of losing a teaching job for 'incompetence', longed in vain for the bliss of a happy conjugal life only to suffer the consequent frustration.

Budget 2026 focuses on pharma and medical tourism, overlooks public health needs: JSAI

By A Representative   Jan Swasthya Abhiyan India (JSAI) has criticised the Union Budget 2026, stating that it overlooks core public health needs while prioritising the pharmaceutical industry, private healthcare, medical tourism, public-private partnerships, and exports related to AYUSH systems. In a press note issued from New Delhi, the public health network said that primary healthcare services and public health infrastructure continue to remain underfunded despite repeated policy assurances.

'Gandhi Talks': Cinema that dares to be quiet, where music, image and silence speak

By Vikas Meshram   In today’s digital age, where reels and short videos dominate attention spans, watching a silent film for over two hours feels almost like an act of resistance. Directed by Kishor Pandurang Belekar, “Gandhi Talks” is a bold cinematic experiment that turns silence into language and wordlessness into a powerful storytelling device. The film is not mere entertainment; it is an experience that pushes the viewer inward, compelling reflection on life, values, and society.

Penpa Tsering’s leadership and record under scrutiny amidst Tibetan exile elections

By Tseten Lhundup*  Within the Tibetan exile community, Penpa Tsering is often described as having risen through grassroots engagement. Born in 1967, he comes from an ordinary Tibetan family, pursued higher education at Delhi University in India, and went on to serve as Speaker of the Tibetan Parliament-in-Exile from 2008 to 2016. In 2021, he was elected Sikyong of the Central Tibetan Administration (CTA), becoming the second democratically elected political leader of the administration after Lobsang Sangay. 

Silencing the university: How fear is replacing debate in academic India

By Sunil Kyumar*  “Republic Day is a powerful symbol of our freedom, Constitution, and democratic values. This festival gives us renewed energy and inspiration to move forward together with the resolve of nation-building”, said Prime Minister Narendra Modi on January 26, 2026. On this occasion, the Prime Minister also shared a Sanskrit subhashita— “Paratantryābhibhūtasya deśasyābhyudayaḥ kutaḥ. Ataḥ svātantryamāptavyaṁ aikyaṁ svātantryasādhanam.”

Harsh Mander moves police over Assam CM’s remarks on Bengali-speaking Muslims

By A Representative   Peace and justice worker and writer Harsh Mander has filed a police complaint against Assam Chief Minister Himanta Biswa Sarma over public statements made on January 27 at an official event in Digboi, Tinsukia district, alleging that the remarks promote hatred, harassment and discrimination against Bengali-speaking Muslims in Assam. 

Advisor appointment rekindles debate on governance in Jammu & Kashmir

By Raqif Makhdoomi*  The government in Jammu and Kashmir has completed approximately one and a half years in office. During the initial phase of its tenure, public expectations were shaped by commitments made during the election campaign. In particular, the Chief Minister, Omar Abdullah, stated at a press conference held at the Sher-i-Kashmir International Conference Centre (SKICC) that major promises would be addressed within the first six months of governance. As the government has now crossed two such six-month periods, public discourse continues to assess the extent to which these commitments have been met.

N-power plant at Mithi Virdi: CRZ nod is arbitrary, without jurisdiction

By Krishnakant* A case-appeal has been filed against the order of the Ministry of Environment, Forest and Climate Change (MoEF&CC) and others granting CRZ clearance for establishment of intake and outfall facility for proposed 6000 MWe Nuclear Power Plant at Mithi Virdi, District Bhavnagar, Gujarat by Nuclear Power Corporation of India Limited (NPCIL) vide order in F 11-23 /2014-IA- III dated March 3, 2015. The case-appeal in the National Green Tribunal at Western Bench at Pune is filed by Shaktisinh Gohil, Sarpanch of Jasapara; Hajabhai Dihora of Mithi Virdi; Jagrutiben Gohil of Jasapara; Krishnakant and Rohit Prajapati activist of the Paryavaran Suraksha Samiti. The National Green Tribunal (NGT) has issued a notice to the MoEF&CC, Gujarat Pollution Control Board, Gujarat Coastal Zone Management Authority, Atomic Energy Regulatory Board and Nuclear Power Corporation of India Limited (NPCIL) and case is kept for hearing on August 20, 2015. Appeal No. 23 of 2015 (WZ) is filed, a...